You just read:

Aeterna Zentaris Announces Results on AEZS-131, a Highly Selective Erk 1/2 Inhibitor Anticancer Compound at American Association for Cancer Research Annual Meeting

News provided by

AETERNA ZENTARIS INC.

Apr 05, 2011, 08:00 ET